Assessing the value of CAN-gene mutations using MALDI-TOF MS

Area of Science:

• Genomics
• Oncology
• Molecular Biology

Background:

• Genome-wide mutation screening identified 140 cancer-linked genes (CAN-genes) in breast cancer.
• These CAN-genes harbor 334 mutations with potential diagnostic and therapeutic applications.

Purpose of the Study:

• To assess the mutation frequency of selected high-ranking breast cancer CAN-genes.
• To validate findings on the low mutation rate of CAN-genes in a specific cohort.

Main Methods:

• Utilized a MALDI-TOF MS 40-plex assay to analyze 40 loci in 21 breast cancer CAN-genes.
• Confirmed mutations using single-plex assays and sequencing.

Main Results:

• Observed a very low mutation rate across the analyzed loci in the sample cohort.
• No mutations were detected in 6 cell lines.
• Identified a single instance of heterozygosity (c.5834G>A) in the ZFYVE26 gene within one breast cancer tissue sample.

Conclusions:

• The study supports previous findings that most CAN-genes are mutated at low frequencies.
• The selected loci likely represent low-frequency mutation events, making them harder to detect in smaller cohorts.
• Further investigation of CAN-gene mutations in larger patient cohorts is recommended.